Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies

Acta Neuropathologica Communications

Volumn 2, Issue 1, 2014, Pages

  Hiniker, Annie ^a   Daniels, Brianne H ^a,b   Lee, Han S ^a   Margeta, Marta ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Touro University California   (United States)

Author keywords

COX negative; Inclusion body myositis; LC3; P62; Polymyositis; TDP 43

Indexed keywords

EID: 85005769239     PISSN: None     EISSN: 20515960     Source Type: Journal    
DOI: 10.1186/2051-5960-1-29     Document Type: Article

References (27)

1. Dalakas MC: Sporadic inclusion body myositis-diagnosis, pathogenesis and therapeutic strategies. Nat Clin Pract Neurol 2006, 2: 437-447. 10.1038/ncpneuro0261
2. Dalakas MC: Review: An update on inflammatory and autoimmune myopathies. Neuropathol Appl Neurobiol 2011, 37: 226-242. 10.1111/j.1365-2990.2010.01153.x
3. Greenberg SA: Inclusion body myositis. Curr Opin Rheumatol 2011, 23: 574-578. 10.1097/BOR.0b013e32834b53cc
4. Askanas V, Engel WK, Nogalska A: Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis. J Neuropathol Exp Neurol 2012, 71: 680-693. 10.1097/NEN.0b013e31826183c8
5. Garlepp MJ, Mastaglia FL: Inclusion body myositis: new insights into pathogenesis. Curr Opin Rheumatol 2008, 20: 662-668. 10.1097/BOR.0b013e328313644c
6. Karpati G, O'Ferrall EK: Sporadic inclusion body myositis: pathogenic considerations. Ann Neurol 2009, 65: 7-11. 10.1002/ana.21622
7. Weihl CC, Pestronk A: Sporadic inclusion body myositis: possible pathogenesis inferred from biomarkers. Curr Opin Neurol 2010, 23: 482-488. 10.1097/WCO.0b013e32833d3897
8. Chahin N, Engel AG: Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM. Neurology 2008, 70: 418-424. 10.1212/01.wnl.0000277527.69388.fe
9. Askanas V, Alvarez RB, Mirabella M, Engel WK: Use of anti-neurofilament antibody to identify paired-helical filaments in inclusion-body myositis. Ann Neurol 1996, 39: 389-391. 10.1002/ana.410390318
10. Dubourg O, Wanschitz J, Maisonobe T, et al.: Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis. Acta Myol 2011, 30: 103-108.
11. Mirabella M, Alvarez RB, Bilak M, Engel WK, Askanas V: Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies. J Neuropathol Exp Neurol 1996, 55: 774-786. 10.1097/00005072-199607000-00003
12. Temiz P, Weihl CC, Pestronk A: Inflammatory myopathies with mitochondrial pathology and protein aggregates. J Neurol Sci 2009, 278: 25-29. 10.1016/j.jns.2008.11.010
13. van der Meulen MF, Hoogendijk JE, Moons KG, Veldman H, Badrising UA, Wokke JH: Rimmed vacuoles and the added value of SMI-31 staining in diagnosing sporadic inclusion body myositis. Neuromuscul Disord 2001, 11: 447-451. 10.1016/S0960-8966(00)00219-4
14. Weihl CC, Temiz P, Miller SE, et al.: TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry 2008, 79: 1186-1189. 10.1136/jnnp.2007.131334
15. D'Agostino C, Nogalska A, Engel WK, Askanas V: In sporadic inclusion body myositis muscle fibres TDP-43-positive inclusions are less frequent and robust than p62 inclusions, and are not associated with paired helical filaments. Neuropathol Appl Neurobiol 2011, 37: 315-320. 10.1111/j.1365-2990.2010.01108.x
16. Salajegheh M, Pinkus JL, Taylor JP, et al.: Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis. Muscle Nerve 2009, 40: 19-31. 10.1002/mus.21386
17. Suzuki T, Nakagawa M, Yoshikawa A, et al.: The first molecular evidence that autophagy relates rimmed vacuole formation in chloroquine myopathy. J Biochem 2002, 131: 647-651. 10.1093/oxfordjournals.jbchem.a003147
18. Lee HS, Daniels BH, Salas E, Bollen AW, Debnath J, Margeta M: Clinical utility of LC3 and p62 immunohistochemistry in diagnosis of drug-induced autophagic vacuolar myopathies: a case-control study. PLoS One 2012, 7: e36221. 10.1371/journal.pone.0036221
19. Nogalska A, D'Agostino C, Terracciano C, Engel WK, Askanas V: Impaired autophagy in sporadic inclusion-body myositis and in endoplasmic reticulum stress-provoked cultured human muscle fibers. Am J Pathol 2010, 177: 1377-1387. 10.2353/ajpath.2010.100050
20. Nogalska A, Terracciano C, D'Agostino C, King Engel W, Askanas V: p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis. Acta Neuropathol 2009, 118: 407-413. 10.1007/s00401-009-0564-6
21. Mehrpour M, Esclatine A, Beau I, Codogno P: Autophagy in health and disease. 1. Regulation and significance of autophagy: an overview. Am J Physiol Cell Physiol 2010, 298: C776-C785. 10.1152/ajpcell.00507.2009
22. Daniels BH, McComb RD, Mobley BC, Gultekin SH, Lee HS, Margeta M: LC3 and p62 as diagnostic markers of drug-induced autophagic vacuolar cardiomyopathy: a study of three cases. Am J Surg Pathol 2013, 37: 1014-1021. 10.1097/PAS.0b013e3182863fa8
23. Badrising UA, Maat-Schieman M, van Duinen SG, et al.: Epidemiology of inclusion body myositis in the Netherlands: a nationwide study. Neurology 2000, 55: 1385-1387. 10.1212/WNL.55.9.1385
24. Blume G, Pestronk A, Frank B, Johns DR: Polymyositis with cytochrome oxidase negative muscle fibres. Early quadriceps weakness and poor response to immunosuppressive therapy. Brain 1997,120(Pt 1):39-45.
25. Girolamo F, Lia A, Amati A, et al.: Overexpression of autophagic proteins in the skeletal muscle of sporadic inclusion body myositis. NeuropatholApplNeurobiol 10.1111/nan.12040
26. Klionsky DJ, Abeliovich H, Agostinis P, et al.: Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008, 4: 151-175.
27. Kusters B, van Hoeve BJ, Schelhaas HJ, TerLaak H, van Engelen BG, Lammens M: TDP-43 accumulation is common in myopathies with rimmed vacuoles. Acta Neuropathol 2009, 117: 209-211. 10.1007/s00401-008-0471-2